Am J Transplant, Volume 19, Suppl 3 Archives - Page 25 of 214 - ATC Abstracts

2019 American Transplant Congress
Attitudes and Knowledge about Organ Donation in a Cohort of Medical Students: Association of Religion and Ethnicity
M. Markell, A. Cerrato, M. Salifu
Nephrology/Medicine, SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Physicians often do not refer appropriate candidates for organ donation and the reasons may be rooted in personal beliefs about transplantation. Students come to…
2019 American Transplant Congress
Overcoming Anti-HLA Sensitization in Kidney Transplantation
R. C. Siqueira¹, P. Malafronte², J. C. Baptista-Silva², E. F. Silva², M. C. Camargo², M. C. Ribeiro Castro²
¹Nephrology Post-Graduation, University of Sao Paulo, São Paulo, Brazil, ²Kidney Transplant Unit, Hospital Samaritano de São Paulo, São Paulo, Brazil
*Purpose: To evaluate if it is possible to achieve good results in kidney transplantation (Ktx) regardless the degree of anti-HLA sensitization.*Methods: 143 adult living (LD)…
2019 American Transplant Congress
Low Dose Anti-Thymocyte Globulin is Enough to Prevent Acute Cellular Rejection in Kidney Transplant
P. W. Baron¹, J. Weissman², F. Fazeli³, C. Zuppan⁴, R. Villicana³, P. Wai¹, L. Beeson⁵, M. De Vera¹
¹Surgery/Transplantation Institute, Loma Linda University Health, Loma Linda, CA, ²Pharmacy, Loma Linda University Health, Loma Linda, CA, ³Transplantation Institute, Loma Linda University Health, Loma Linda, CA, ⁴Pathology, Loma Linda University Health, Loma Linda, CA, ⁵Center for Nutrition, Healthy Lifestyle and Disease Prevention/School of Public Health, Loma Linda University Health, Loma Linda, CA
*Purpose: Rabbit anti-thymocyte globulin (rATG) cumulative dose needed to effectively and safely prevent acute cellular rejection is unknown. This study compares the efficacy of total…
2019 American Transplant Congress
Multidisciplinary Transplant UTI Service; Challenging the Stalemate
J. J. Chong, A. Adiki, D. Ness, J. Olsburgh, R. H. Zakri
Guy's Hospital, London, United Kingdom
*Purpose: Symptomatic UTIs (urinary tract infections) cause a significantly detrimental effect on long term graft function. Immunosuppression coupled with underlying renal or urological abnormality makes…
2019 American Transplant Congress
The Natural History and Time to Seroconversion of CMV in the Era of Post-Transplantation Chemoprophylaxis: A Single Center Study
S. Farran, T. Zangeneh, M. Al-Obaidi
Division of Infectious Diseases, University of Arizona, Tucson, AZ
*Purpose: The current cytomegalovirus (CMV) guidelines in solid organ transplantation recommend chemoprophylaxis (ppx) in post-kidney transplantation recipients. This approach has led to a reduction in…
2019 American Transplant Congress
Quality of Life in Tolerant Living Donor Kidney Transplants vs. Standard of Care
D. Tollerud¹, J. Leventhal², J. Galvin², J. Mathew², L. Gallon², D. Stare², J. Miller², M. Abecassis², S. Ildstad³
¹Regenerex, Inc., Louisville, KY, ²Northwestern U, Chicago, IL, ³U of Louisville, Louisville, KY
*Purpose: 37 subjects have been transplanted since 2009 in a phase 2 protocol to induce tolerance in recipients of living donor renal allografts. The protocol…
2019 American Transplant Congress
Chylous Ascites Following Laparoscopic Live Donor Nephrectomy: A New Improved Treatment Paradigm
L. Dale¹, R. Sandoval², L. E. Ratner²
¹Columbia University Vagelos College of Physicians and Surgeons, New York, NY, ²Surgery, Columbia University Medical Center, New York, NY
*Purpose: To illustrate prompt, initial placement of a percutaneous drain is an alternative treatment of chylous ascites after laparoscopic live donor nephrectomy.*Methods: We identified three…
2019 American Transplant Congress
Complex Live Donor Anatomy Does Not Preclude Kidney Transplantation
P. Veitch, T. Brown, A. Courtney, J. McDaid
Transplant Department, Belfast City Hospital, Belfast, United Kingdom
*Purpose: Living donor (LD) kidney transplantation is the optimum form of renal replacement therapy for suitable patients. Decline of otherwise suitable potential donors on the…
2019 American Transplant Congress
Clinical Impact of Spontaenous Portosystemic Shunts on the Short Term Outcome of Liver Transplantation
E. A. Rodriguez¹, R. M. Perez², N. Zhang³, E. S. Lim³, C. R. Miller⁴, M. A. Schwartz², A. J. McGirr⁴, A. Srinivasan⁵, W. R. Hewitt⁵, A. C. Silva⁴, J. Rakela¹, H. E. Vargas¹
¹Transplant Hepatology, Mayo Clinic Arizona, Phoenix, AZ, ²Mayo Clinic School of Medicine, Mayo Clinic Arizona, Phoenix, AZ, ³Division of Health Sciences Research, Mayo Clinic Arizona, Phoenix, AZ, ⁴Radiology, Mayo Clinic Arizona, Phoenix, AZ, ⁵Transplant Surgery, Mayo Clinic Arizona, Phoenix, AZ
*Purpose: The aim of our study was to compare Liver Transplant (LT) candidates with and without spontaneous portosystemic shunts (SPSS) and assess their impact on…
2019 American Transplant Congress
Treatment of Cardiovascular Risk Factors Improves Long Term Outcome Post Liver Transplantation
S. Alghamdi, O. Altayar, T. Zhu, A. Bayudan, J. Fleckenstein, M. Lisker-Melman, J. Crippin, A. Flores
Washington University in St Louis, Saint Louis, MO
*Purpose: Cardiovascular (CV) disease is a leading cause of mortality 1 year after liver transplantation (LT). We aimed to assess the effect of treating CV…